Skip to main content

and
  1. No Access

    Article

    Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor

    Allogeneic hematopoietic stem cell transplantation is the only potentially curative therapy for acute myeloid leukemia. In the absence of an HLA-matched related or unrelated donor (MRD or MUD), the best altern...

    Clémence Deteix, Florence Mesnil, Sabine Furst, Noel Milpied in Bone Marrow Transplantation (2020)

  2. Article

    Open Access

    Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    John A. Snowden, Riccardo Saccardi, Kim Orchard in Bone Marrow Transplantation (2020)

  3. Article

    Open Access

    Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    In many healthcare settings, benchmarking for complex procedures has become a mandatory requirement by competent authorities, regulators, payers and patients to assure clinical performance, cost-effectiveness ...

    John A. Snowden, Riccardo Saccardi, Kim Orchard in Bone Marrow Transplantation (2020)